Viridian Therapeutics Strikes Commercial Manufacturing Services Agreement With WuXi Biologics To Produce, Supply Veligrotug Drug Substance, Drug Product

Benzinga Newsdesk www.benzinga.com Neutral 92.5%

Neg 0% Neu 92.5% Pos 0%

https://www.sec.gov/ix?doc=/Archives/edgar/data/1590750/000119312526239246/d111034d8k.htm

Comments

No comments yet. Be the first!